Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dichloroacetate and cancer: New home for an orphan drug?
Shyam Kankotia, Peter W. Stacpoole
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 617-629
Closed Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications
Jacek Zielonka, Joy Joseph, Adam Sikora, et al.
Chemical Reviews (2017) Vol. 117, Iss. 15, pp. 10043-10120
Open Access | Times Cited: 1305
mTOR signalling and cellular metabolism are mutual determinants in cancer
Dirk Mossmann, Sujin Park, Michael N. Hall
Nature reviews. Cancer (2018) Vol. 18, Iss. 12, pp. 744-757
Open Access | Times Cited: 896
Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect
Iñigo San-Millán, George A. Brooks
Carcinogenesis (2016), pp. bgw127-bgw127
Open Access | Times Cited: 546
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny, Celine J. Marmion
Chemical Reviews (2019) Vol. 119, Iss. 2, pp. 1058-1137
Closed Access | Times Cited: 536
Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Nerino Allocati, Michele Masulli, Carmine Di Ilio, et al.
Oncogenesis (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 513
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
Ali F. Abdel-Wahab, Waheed Mahmoud, Randa M. Al-Harizy
Pharmacological Research (2019) Vol. 150, pp. 104511-104511
Closed Access | Times Cited: 470
Interplay between metabolic identities in the intestinal crypt supports stem cell function
Maria J. Rodríguez Colman, Matthias Schewe, Maaike Meerlo, et al.
Nature (2017) Vol. 543, Iss. 7645, pp. 424-427
Closed Access | Times Cited: 442
Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions
Ashley V. Menk, Nicole E. Scharping, Rebecca S. Moreci, et al.
Cell Reports (2018) Vol. 22, Iss. 6, pp. 1509-1521
Open Access | Times Cited: 399
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
Peter W. Stacpoole
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 11
Open Access | Times Cited: 329
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Gabriela Andrejeva, Jeffrey C. Rathmell
Cell Metabolism (2017) Vol. 26, Iss. 1, pp. 49-70
Open Access | Times Cited: 316
The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents
Elise F. Saunier, Chantal Benelli, Sylvie Bortoli
International Journal of Cancer (2015) Vol. 138, Iss. 4, pp. 809-817
Open Access | Times Cited: 200
Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications
Tiziana Tataranni, Cláudia Piccoli
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 192
The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
Eric S. Goetzman, Edward V. Prochownik
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 174
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Katherine G. Roth, Isa Mambetsariev, Prakash Kulkarni, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 1, pp. 119-134
Open Access | Times Cited: 161
Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn’s disease recurrence
Sevana Khaloian, Eva Rath, Nassim Hammoudi, et al.
Gut (2020) Vol. 69, Iss. 11, pp. 1939-1951
Open Access | Times Cited: 154
Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
Hui Wang, Heng Jiang, Melissa Van De Gucht, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 112-112
Open Access | Times Cited: 150
Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
Saleha Anwar, Anas Shamsi, Taj Mohammad, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188568-188568
Closed Access | Times Cited: 111
Metabolic regulation of species-specific developmental rates
Margarete Díaz-Cuadros, Teemu P. Miettinen, Owen S. Skinner, et al.
Nature (2023) Vol. 613, Iss. 7944, pp. 550-557
Open Access | Times Cited: 93
Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Cyril Corbet, Olivier Féron
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 1, pp. 7-15
Closed Access | Times Cited: 155
Role of the Pyruvate Dehydrogenase Complex in Metabolic Remodeling: Differential Pyruvate Dehydrogenase Complex Functions in Metabolism
Sungmi Park, Jae‐Han Jeon, Byong-Keol Min, et al.
Diabetes & Metabolism Journal (2018) Vol. 42, Iss. 4, pp. 270-270
Open Access | Times Cited: 152
Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?
Reece G. Kenny, Su Wen Chuah, Alanna Crawford, et al.
European Journal of Inorganic Chemistry (2016) Vol. 2017, Iss. 12, pp. 1596-1612
Open Access | Times Cited: 151
Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
Wen Zhang, Shaolin Zhang, Xiaohui Hu, et al.
International Journal of Biological Sciences (2015) Vol. 11, Iss. 12, pp. 1390-1400
Open Access | Times Cited: 137
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
Timm Hoeres, Manfred Smetak, Dominik Pretscher, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 135
Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
Emanuele Petruzzella, Roman Sirota, Irene Solazzo, et al.
Chemical Science (2018) Vol. 9, Iss. 18, pp. 4299-4307
Open Access | Times Cited: 131
p53 and metabolism: from mechanism to therapeutics
Fernando Moreira Simabuco, Mirian Galliote Morale, Isadora Carolina Betim Pavan, et al.
Oncotarget (2018) Vol. 9, Iss. 34, pp. 23780-23823
Open Access | Times Cited: 127
Page 1 - Next Page

Scroll to top